Bis-cysteine selective modifications were successfully applied with melarsen oxide (MEL), an arsonous acid derivative, for tertiary structural studies of peptides and a model protein. The arsonous acid modified peptides and proteins were amenable to direct characterizations by mass spectrometry, e.g., direct molecular weight determinations and mass spectrometric peptide mapping that identified stoichiometry and sites of modification, respectively. Proteolytic digestion and mass spectrometric fragmentation of modified oxytocin showed that MEL-bridged peptide derivatives are structural homologues to the disulfide-bonded macrocyclic peptides. Mass spectrometric analyses determined the MEL modification site in partially reduced and selectively modified bovine pancreatic trypsin inhibitor (BPTI) bridging Cys-14 and Cys-38. The BPTI.MEL derivative was resistant to proteolysis by both Lys-C and trypsin and thus represented a rigid structure like native BPTI. MEL exhibited several advantageous features such as (i) cross-linking two closely spaced thiol groups, providing detailed tertiary structure information; (ii) high solubility as monomeric ortho acid in aqueous and organic solutions; (iii) adding a relatively large mass increment to proteins upon single modification; (iv) enabling UV monitoring of the derivatization due to a strong chromophor; and (v) performing fast and specific modifications of bis-thiol groups in proteins to form stable structures without any side reactions even with a high molar excess of MEL. The investigated physical and chemical properties of MEL suggest general applicability for selective bis-thiol modifications, enabling protein structure-function studies in both soluble and membrane proteins and the study of protein-folding reactions.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1006/abio.1998.2836 | DOI Listing |
Dokl Biochem Biophys
October 2024
Arbuzov Institute of Organic and Physical Chemistry, Kazan Scientific Center of the Russian Academy of Sciences, Kazan, Russia.
One of the main modern approaches to the creation of effective drugs is the design of new biologically active substances containing two or more pharmacophore groups in their structure. In recent years, there have been many publications on the synthesis and study of biological activity, including antitumour activity, of new organo-arsenic compounds. It is known that spatially hindered phenols can also have antitumor activity, so the synthesis and study of hybrid compounds based on organo-arsenic compounds and spatially hindered phenols is a relevant area of research.
View Article and Find Full Text PDFInorg Chem
October 2024
School of Science, Constructor University, Campus Ring 1, Bremen 28759, Germany.
We report on the synthesis and structural characterization of six novel arylarsonate-containing polyoxomolybdates with fluorinated-functionalities in the position of the phenyl ring. The reaction of the various arylarsonic acids, RAsOH [ = 4-F-CH (H), 4-FC-CH (H), 4-FCO-CH (H)] with NaMoO·2HO in aqueous pH 3 solution resulted in the heteropoly-6-molybdates [{(4-F-CH)As}MoO(HO)] (), [{(4-FC-CH)As}MoO] () and [{(4-FCO-CH)As}MoO(HO)] (), which were isolated as guanidinium salts. When the reaction was performed in aqueous pH 1 solution the inverted-Keggin type heteropoly-12-molydates [{(4-F-CH)As}MoO] (), [{(4-FC-CH)As}MoO] () and [{(4-FCO-CH)As}MoO] (), were obtained and isolated as sodium salts.
View Article and Find Full Text PDFInt J Mol Sci
April 2024
Department of Pediatric Hematology/Oncology, Children's Hospital Cologne, Amsterdamer Straße 59, 50735 Cologne, Germany.
Cancer treatment is greatly challenged by drug resistance, highlighting the need for novel drug discoveries. Here, we investigated novel organoarsenic compounds regarding their resistance-breaking and apoptosis-inducing properties in leukemia and lymphoma. Notably, the compound (2,6-dimethylphenyl)arsonic acid (As2) demonstrated significant inhibition of cell proliferation and induction of apoptosis in leukemia and lymphoma cells while sparing healthy leukocytes.
View Article and Find Full Text PDFActa Crystallogr E Crystallogr Commun
November 2023
ICMUB UMR 6302, Université de Bourgogne (UB), Faculté des Sciences, 9 avenue Alain Savary, 21000 DIJON, France.
The title salt, CHN·CHAsNO ·HO or [(CHCH)NH][HNCHAs(OH)O]·HO, (), was synthesized by mixing an aqueous solution of (4-amino-phenyl)-arsonic acid with an ethano-lic solution of di-benzyl-amine at room temperature. Compound crystallizes in the monoclinic 2/c space group. The three components forming are linked N-H⋯O and O-H⋯O inter-molecular hydrogen bonds, resulting in the propagation of an infinite zigzag chain.
View Article and Find Full Text PDFJ Am Chem Soc
August 2023
Department of Life Science, Faculty of Science, Gakushuin University, 1-5-1 Mejiro, Toshima, Tokyo 171-8588, Japan.
The unique bioactivities of arsenic-containing secondary metabolites have been revealed recently, but studies on arsenic secondary metabolism in microorganisms have been extremely limited. Here, we focused on the organoarsenic metabolite with an unknown chemical structure, named bisenarsan, produced by well-studied model actinomycetes and elucidated its structure by combining feeding of the putative biosynthetic precursor (2-hydroxyethyl)arsonic acid to 1326 and detailed NMR analyses. Bisenarsan is the first characterized actinomycete-derived arsenic secondary metabolite and may function as a prototoxin form of an antibacterial agent or be a detoxification product of inorganic arsenic species.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!